Search details
1.
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 23(7): 876-887, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35636444
2.
Transient protein accumulation at the center of the T cell antigen-presenting cell interface drives efficient IL-2 secretion.
Elife
; 82019 10 30.
Article
in English
| MEDLINE | ID: mdl-31663508
Results
1 -
2
de 2
1
Next >
>>